Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1848 1
1863 1
1868 5
1869 1
1884 3
1885 4
1886 2
1887 1
1888 1
1889 2
1890 2
1892 2
1893 1
1894 2
1899 1
1907 2
1915 1
1916 1
1918 1
1920 1
1924 1
1926 1
1929 2
1930 1
1931 1
1933 1
1934 1
1935 1
1942 1
1944 1
1946 6
1947 12
1948 6
1949 4
1950 9
1951 10
1952 12
1953 9
1954 10
1955 13
1956 12
1957 9
1958 1
1959 10
1960 6
1961 8
1962 6
1963 5
1964 12
1965 11
1966 8
1967 2
1968 6
1969 8
1970 15
1971 9
1972 4
1973 7
1974 8
1975 6
1976 10
1977 17
1978 12
1979 24
1980 18
1981 18
1982 13
1983 16
1984 18
1985 23
1986 28
1987 37
1988 39
1989 40
1990 40
1991 35
1992 27
1993 36
1994 33
1995 26
1996 39
1997 23
1998 29
1999 34
2000 35
2001 42
2002 27
2003 36
2004 45
2005 26
2006 34
2007 39
2008 62
2009 42
2010 46
2011 57
2012 56
2013 69
2014 74
2015 105
2016 102
2017 110
2018 105
2019 103
2020 128
2021 136
2022 133
2023 120
2024 58

Text availability

Article attribute

Article type

Publication date

Search Results

2,526 results

Results by year

Filters applied: . Clear all
Page 1
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Dickinson MJ, Carlo-Stella C, Morschhauser F, Bachy E, Corradini P, Iacoboni G, Khan C, Wróbel T, Offner F, Trněný M, Wu SJ, Cartron G, Hertzberg M, Sureda A, Perez-Callejo D, Lundberg L, Relf J, Dixon M, Clark E, Humphrey K, Hutchings M. Dickinson MJ, et al. Among authors: clark e. N Engl J Med. 2022 Dec 15;387(24):2220-2231. doi: 10.1056/NEJMoa2206913. Epub 2022 Dec 11. N Engl J Med. 2022. PMID: 36507690 Clinical Trial.
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up.
Piccart M, Procter M, Fumagalli D, de Azambuja E, Clark E, Ewer MS, Restuccia E, Jerusalem G, Dent S, Reaby L, Bonnefoi H, Krop I, Liu TW, Pieńkowski T, Toi M, Wilcken N, Andersson M, Im YH, Tseng LM, Lueck HJ, Colleoni M, Monturus E, Sicoe M, Guillaume S, Bines J, Gelber RD, Viale G, Thomssen C; APHINITY Steering Committee and Investigators. Piccart M, et al. Among authors: clark e. J Clin Oncol. 2021 May 1;39(13):1448-1457. doi: 10.1200/JCO.20.01204. Epub 2021 Feb 4. J Clin Oncol. 2021. PMID: 33539215 Free article. Clinical Trial.
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study.
Swain SM, Miles D, Kim SB, Im YH, Im SA, Semiglazov V, Ciruelos E, Schneeweiss A, Loi S, Monturus E, Clark E, Knott A, Restuccia E, Benyunes MC, Cortés J; CLEOPATRA study group. Swain SM, et al. Among authors: clark e. Lancet Oncol. 2020 Apr;21(4):519-530. doi: 10.1016/S1470-2045(19)30863-0. Epub 2020 Mar 12. Lancet Oncol. 2020. PMID: 32171426 Clinical Trial.
GPNMB confers risk for Parkinson's disease through interaction with α-synuclein.
Diaz-Ortiz ME, Seo Y, Posavi M, Carceles Cordon M, Clark E, Jain N, Charan R, Gallagher MD, Unger TL, Amari N, Skrinak RT, Davila-Rivera R, Brody EM, Han N, Zack R, Van Deerlin VM, Tropea TF, Luk KC, Lee EB, Weintraub D, Chen-Plotkin AS. Diaz-Ortiz ME, et al. Among authors: clark e. Science. 2022 Aug 19;377(6608):eabk0637. doi: 10.1126/science.abk0637. Epub 2022 Aug 19. Science. 2022. PMID: 35981040 Free PMC article.
Canadian Association of Radiologists Guidance on Contrast Associated Acute Kidney Injury.
Macdonald DB, Hurrell C, Costa AF, McInnes MDF, O'Malley ME, Barrett B, Brown PA, Clark EG, Hadjivassiliou A, Kirkpatrick IDC, Rempel JL, Jeon PM, Hiremath S. Macdonald DB, et al. Among authors: clark eg. Can Assoc Radiol J. 2022 Aug;73(3):499-514. doi: 10.1177/08465371221083970. Epub 2022 May 24. Can Assoc Radiol J. 2022. PMID: 35608223 Free article.
CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary Angioedema.
Longhurst HJ, Lindsay K, Petersen RS, Fijen LM, Gurugama P, Maag D, Butler JS, Shah MY, Golden A, Xu Y, Boiselle C, Vogel JD, Abdelhady AM, Maitland ML, McKee MD, Seitzer J, Han BW, Soukamneuth S, Leonard J, Sepp-Lorenzino L, Clark ED, Lebwohl D, Cohn DM. Longhurst HJ, et al. Among authors: clark ed. N Engl J Med. 2024 Feb 1;390(5):432-441. doi: 10.1056/NEJMoa2309149. N Engl J Med. 2024. PMID: 38294975 Clinical Trial.
Arthropod segmentation.
Clark E, Peel AD, Akam M. Clark E, et al. Development. 2019 Sep 25;146(18):dev170480. doi: 10.1242/dev.170480. Development. 2019. PMID: 31554626 Free article. Review.
2,526 results